Orchard Therapeutics
Trending Articles
Related Content
Media
Orchard Therapeutics and Généthon announce gene therapy alliance
Orchard Therapeutics, a clinical-stage biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative gene therapies announces today a strategic alliance with Généthon, to develop gene therapy for X-linked chronic granulomatous disease (“X-CGD”)